BR112021026471A2 - Formulações de dose sólida para a liberação sem agulha - Google Patents
Formulações de dose sólida para a liberação sem agulhaInfo
- Publication number
- BR112021026471A2 BR112021026471A2 BR112021026471A BR112021026471A BR112021026471A2 BR 112021026471 A2 BR112021026471 A2 BR 112021026471A2 BR 112021026471 A BR112021026471 A BR 112021026471A BR 112021026471 A BR112021026471 A BR 112021026471A BR 112021026471 A2 BR112021026471 A2 BR 112021026471A2
- Authority
- BR
- Brazil
- Prior art keywords
- needle
- solid dose
- free delivery
- dose formulations
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000007787 solid Substances 0.000 title abstract 4
- 229920002307 Dextran Polymers 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
formulações de dose sólida para a liberação sem agulha. a presente divulgação se refere a formulações de dose sólida para a liberação sem agulha compreendendo 0,01 a 60 (p/p) de um ou mais agentes terapêuticos e/ou agentes profiláticos; e 40,0 % a 99,99 % (p/p) de dextrano. a invenção se refere ainda a métodos de produzir um comprimido de formulação de dose sólida e aplicação aos seus usos médicos particulares, em particular como uma vacina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909280.8A GB201909280D0 (en) | 2019-06-27 | 2019-06-27 | Solid dose formulation |
| PCT/GB2020/051541 WO2020260882A1 (en) | 2019-06-27 | 2020-06-25 | Solid dose formulations for needle-free delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021026471A2 true BR112021026471A2 (pt) | 2022-02-08 |
Family
ID=67539927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021026471A BR112021026471A2 (pt) | 2019-06-27 | 2020-06-25 | Formulações de dose sólida para a liberação sem agulha |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220249379A1 (pt) |
| EP (1) | EP3990092A1 (pt) |
| JP (1) | JP2022538297A (pt) |
| KR (1) | KR20220027214A (pt) |
| CN (1) | CN114025827A (pt) |
| AU (1) | AU2020307235A1 (pt) |
| BR (1) | BR112021026471A2 (pt) |
| CA (1) | CA3144204A1 (pt) |
| GB (1) | GB201909280D0 (pt) |
| IL (1) | IL289194A (pt) |
| WO (1) | WO2020260882A1 (pt) |
| ZA (1) | ZA202200282B (pt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002542183A (ja) | 1999-04-16 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | 成形可能な乾燥した医薬製剤 |
| GB2391480B (en) | 2002-08-05 | 2007-02-28 | Caretek Medical Ltd | Drug delivery system |
| GB2379390B (en) | 2001-09-11 | 2005-01-26 | Caretek Medical Ltd | A novel drug delivery technology |
| GB2422784A (en) | 2005-02-07 | 2006-08-09 | Caretek Medical Ltd | Disposable assembly comprising a needle or stylet |
| GB2446780A (en) | 2007-02-22 | 2008-08-27 | Glide Pharmaceutical Technolog | An elongate parenteral injection body having an injection point of angle 10 to 40 degrees. |
| ES2362525B8 (es) | 2009-10-08 | 2013-01-03 | Azurebio, S.L. | Formulación de medicamentos en forma de agujas percutaneas penetrantes. |
| GB201501697D0 (en) | 2015-02-02 | 2015-03-18 | Glide Pharmaceutical Technologies Ltd | Injection device |
| GB2545880A (en) | 2015-10-20 | 2017-07-05 | Glide Pharmaceutical Tech Ltd | Solid formulation |
-
2019
- 2019-06-27 GB GBGB1909280.8A patent/GB201909280D0/en not_active Ceased
-
2020
- 2020-06-25 US US17/622,578 patent/US20220249379A1/en active Pending
- 2020-06-25 EP EP20735673.4A patent/EP3990092A1/en active Pending
- 2020-06-25 CN CN202080046949.9A patent/CN114025827A/zh active Pending
- 2020-06-25 CA CA3144204A patent/CA3144204A1/en active Pending
- 2020-06-25 JP JP2021577404A patent/JP2022538297A/ja active Pending
- 2020-06-25 KR KR1020227003309A patent/KR20220027214A/ko unknown
- 2020-06-25 BR BR112021026471A patent/BR112021026471A2/pt unknown
- 2020-06-25 WO PCT/GB2020/051541 patent/WO2020260882A1/en active Application Filing
- 2020-06-25 AU AU2020307235A patent/AU2020307235A1/en active Pending
-
2021
- 2021-12-21 IL IL289194A patent/IL289194A/en unknown
-
2022
- 2022-01-05 ZA ZA2022/00282A patent/ZA202200282B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220027214A (ko) | 2022-03-07 |
| IL289194A (en) | 2022-02-01 |
| EP3990092A1 (en) | 2022-05-04 |
| ZA202200282B (en) | 2023-07-26 |
| WO2020260882A1 (en) | 2020-12-30 |
| CN114025827A (zh) | 2022-02-08 |
| US20220249379A1 (en) | 2022-08-11 |
| GB201909280D0 (en) | 2019-08-14 |
| AU2020307235A1 (en) | 2022-02-17 |
| CA3144204A1 (en) | 2020-12-30 |
| JP2022538297A (ja) | 2022-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018073663A2 (pt) | moduladores de receptores nmda spiro-lactâmicos e seus usos | |
| PH12020550341A1 (en) | Niraparib formulations | |
| MX2023006541A (es) | Formulaciones de dosis fija. | |
| BR112014031394A8 (pt) | Composições compreendendo ciclobenzaprina ou amitriptilina e seus usos via absorção transmucosa oral | |
| MX2016011975A (es) | Metodos para reducir el riesgo cardiovascular. | |
| CA3030422C (en) | Stabilizing excipients for therapeutic protein formulations | |
| MX2021010359A (es) | Una composicion farmaceutica para reducir la grasa localizada y sus usos. | |
| MX2020005518A (es) | Mezclas no racemicas y usos de las mismas. | |
| MX2017004772A (es) | Composiciones y métodos para la administración fisiológica utilizando cannabidiol. | |
| BR112021017878A2 (pt) | Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação | |
| MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
| BR112017009510A2 (pt) | composições compreendendo ciclosporina | |
| MX2016016400A (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| MX2017005163A (es) | Composiciones de liberación prolongada de onapristona y métodos. | |
| BR112018007399A2 (pt) | composição, método de tratamento, kit de partes e forma de dosagem | |
| MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
| PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
| BR112021026471A2 (pt) | Formulações de dose sólida para a liberação sem agulha | |
| CL2022000095A1 (es) | Composiciones farmacéuticas resistentes a la descarga de dosis que comprenden venirunad | |
| MX2017013643A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz. | |
| BR112018008835A8 (pt) | composição farmacêutica oral, composição farmacêutica de liberação pulsátil oral, método para tratar uma condição de doença que requer terapia com fumarato de dimetila e método para tratar esclerose múltipla | |
| MX2021007032A (es) | Derivados activos de éster de testosterona, composiciones y usos de los mismos. | |
| MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
| MX2020007062A (es) | Composiciones farmacéuticas para la piel tópicas que contienen cerdulatinib y usos de estas. | |
| MX2018008196A (es) | Tratamiento para cancer de mama usando una combinacion de una formulacion liposomal cationica de taxano, una formulacion no liposomal de taxano y un agente activo adicional. |